Skip to main content

Psychemedics Corporation (PMD)

NASDAQ: PMD · Delayed Price · USD
7.90
0.46 (6.26%)
At close: Dec 8, 2021 4:00 PM
7.83
-0.06 (-0.82%)
After-hours:Dec 8, 2021 4:00 PM EST
Market Cap43.76M
Revenue (ttm)23.81M
Net Income (ttm)413,000
Shares Out5.54M
EPS (ttm)0.07
PE Ratio109.65
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume3,737
Open7.64
Previous Close7.43
Day's Range7.58 - 7.90
52-Week Range4.13 - 8.90
Beta0.77
Analystsn/a
Price Targetn/a
Earnings DateNov 15, 2021

About PMD

Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States, Brazil, and internationally. The company offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, PCP, amphetamines, opiates, synthetic cannabinoids, and benzodiazepines. Its testing results provide quantitative information that can indicate the approximate amount of drug ingested, as well as historical data that can show a pattern of individual ...

IndustryHealth Care Providers & Services
Founded1986
Employees138
Stock ExchangeNASDAQ
Ticker SymbolPMD
Full Company Profile

Financial Performance

Financial Statements

News

Psychemedics Corporation Reports Stronger Revenue, Operating Profit and Earnings Growth in Third Quarter 2021

ACTON, Mass., Nov. 12, 2021 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world's largest provider of hair testing for drugs of abuse, today announced financial results for the third qu...

3 weeks ago - GlobeNewsWire

Psychemedics Corporation Reports Stronger Second Quarter 2021 Financial Results

ACTON, Mass., Aug. 10, 2021 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world's largest provider of hair testing for drugs of abuse, today announced financial results for the second q...

3 months ago - GlobeNewsWire

5 Undervalued Stocks Trading Below the Peter Lynch Value

According to the GuruFocus All-in-One Screener, a Premium feature, as of June 28, the following companies are trading below their Peter Lynch fair values with wide margins of safety and have had positiv...

Other symbols:BDNGPINNITPH
5 months ago - GuruFocus

Montana Advisors Writes Open Letter to Psychemedics

MIAMI--(BUSINESS WIRE)---- $PMD--Montana Advisors issues open letter to Psychemedics CEO (Nasdaq: PMD): Dear Kubacki: It was a pleasure speaking with you two months ago via Zoom. I appreciate the time y...

6 months ago - Business Wire

Psychemedics Corporation Reports First Quarter 2021 Financial Results

ACTON, Mass., May 10, 2021 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world's largest provider of hair testing for drugs of abuse, today announced financial results for the first qua...

6 months ago - GlobeNewsWire

Psychemedics Corporation Reports Fourth Quarter and Full Year 2020 Financial Results

ACTON, Mass., March 23, 2021 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world's largest provider of hair testing for drugs of abuse, today announced fourth quarter and full year fina...

8 months ago - GlobeNewsWire

Robyn C. Davis Joins Psychemedics Board of Directors

ACTON, Mass., March 17, 2021 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD) announced that Robyn C. Davis was unanimously elected to serve on the Board of Directors of Psychemedics Corporati...

8 months ago - GlobeNewsWire

Andrew Limbek Joins Psychemedics Corporation as Vice President, Controller

ACTON, Mass., Jan. 26, 2021 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD) announced that Andrew Limbek has joined the Company as Vice President, Controller.

10 months ago - GlobeNewsWire

Sarah Ashby Rejoins Psychemedics Corporation as Vice President, General Counsel

ACTON, Mass., Dec. 17, 2020 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD) announced that Sarah Ashby has rejoined the company as Vice President, General Counsel.

11 months ago - GlobeNewsWire

Psychemedics Announces Third Quarter Results

ACTON, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD) today announced third quarter financial results for the period ended September 30, 2020.

1 year ago - GlobeNewsWire

Psychemedics Announces Second Quarter Results

ACTON, Mass., Aug. 12, 2020 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD) today announced second quarter financial results for the period ended June 30, 2020. 

1 year ago - GlobeNewsWire

Psychemedics Announces First Quarter Results

ACTON, Mass., May 13, 2020 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD) today announced first quarter financial results for the period ended March 31, 2020. 

1 year ago - GlobeNewsWire

Psychemedics Test for Cotinine (metabolite of Nicotine) Detection Cleared by FDA

A New and Cost-Effective Tool to Detect and Deter Nicotine use A New and Cost-Effective Tool to Detect and Deter Nicotine use

1 year ago - GlobeNewsWire

Top Marijuana Stocks on the NASDAQ

The cannabis industry has grown in recent months and years, and many companies in the cannabis and health-related industries have been uplisted to reputable U.S. exchanges.

1 year ago - Investopedia

Psychemedics Corporation Responds to Court Decision

ACTON, Mass., Oct. 31, 2019 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD) today issued a response to a Massachusetts Supreme Judicial Court ruling in the case of Boston Police Department v...

2 years ago - GlobeNewsWire

Psychemedics Corporation Announces New Brazilian Distribution Agreement

ACTON, Mass., Sept. 19, 2019 (GLOBE NEWSWIRE) -- Psychemedics Corporation (Nasdaq:PMD) announced today that it has entered into a new distribution agreement in Brazil with Sansão Holding S.A. and with...

2 years ago - GlobeNewsWire